Relationship between protein arginine methyltransferase and cardiovascular disease (Review)
- Authors:
- Sisi Zheng
- Congcong Zeng
- Ailing Huang
- Fuqi Huang
- Anna Meng
- Zhuan Wu
- Shouhong Zhou
-
Affiliations: Guangxi Key Laboratory of Brain and Cognitive Neuroscience, Guilin Medical University, Guilin, Guangxi 541199, P.R. China, Central Laboratory, Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541199, P.R. China - Published online on: September 16, 2022 https://doi.org/10.3892/br.2022.1572
- Article Number: 90
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
Lin WJ, Gary JD, Yang MC, Clarke S and Herschman HR: The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J Biol Chem. 271:15034–15044. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Wang J, Tan GJ, Han LN, Bai YY, He M and Liu HB: Novel biomarkers for cardiovascular risk prediction. J Geriatr Cardiol. 14:135–150. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Zhao D, Liu J, Wang M, Zhang X and Zhou M: Epidemiology of cardiovascular disease in China: Current features and implications. Nat Rev Cardiol. 16:203–212. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Jarrold J and Davies CC: PRMTs and arginine methylation: Cancer's best-kept secret? Trends Mol Med. 25:993–1009. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Yang Y and Bedford MT: Protein arginine methyltransferases and cancer. Nat Rev Cancer. 13:37–50. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Zhang W, Song M, Qu J and Liu GH: Epigenetic modifications in cardiovascular aging and diseases. Circ Res. 123:773–786. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Al-Hamashi AA, Diaz K and Huang R: Non-histone arginine methylation by protein arginine methyltransferases. Curr Protein Pept Sci. 21:699–712. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Xu S, Pelisek J and Jin ZG: Atherosclerosis is an epigenetic disease. Trends Endocrinol Metab. 29:739–742. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Yang Y and Luan Y, Yuan RX and Luan Y: Histone methylation related therapeutic challenge in cardiovascular diseases. Front Cardiovasc Med Sep. 8(710053)2021.PubMed/NCBI View Article : Google Scholar | |
|
Rakow S, Pullamsetti SS, Bauer UM and Bouchard C: Assaying epigenome functions of PRMTs and their substrates. Methods. 175:53–65. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Couto E Silva A, Wu CY, Citadin CT, Clemons GA, Possoit HE, Grames MS, Lien CF, Minagar A, Lee RH, Frankel A and Lin HW: Protein arginine methyltransferases in cardiovascular and neuronal function. Mol Neurobiol. 57:1716–1732. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Larsen SC, Sylvestersen KB, Mund A, Lyon D, Mullari M, Madsen MV, Daniel JA, Jensen LJ and Nielsen ML: Proteome-wide analysis of arginine monomethylation reveals widespread occurrence in human cells. Sci Signal. 9(rs9)2016.PubMed/NCBI View Article : Google Scholar | |
|
Blanc RS and Richard S: Arginine methylation: The coming of age. Mol Cell. 65:8–24. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Morales Y, Cáceres T, May K and Hevel JM: Biochemistry and regulation of the protein arginine methyltransferases (PRMTs). Arch Biochem Biophys. 590:138–152. 2016.PubMed/NCBI View Article : Google Scholar | |
|
vanLieshout TL and Ljubicic V: The emergence of protein arginine methyltransferases in skeletal muscle and metabolic disease. Am J Physiol Endocrinol Metab. 317:E1070–E1080. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Hu G, Yan C, Xie P, Cao Y, Shao J and Ge J: PRMT2 accelerates tumorigenesis of hepatocellular carcinoma by activating Bcl2 via histone H3R8 methylation. Exp Cell Res. 394(112152)2020.PubMed/NCBI View Article : Google Scholar | |
|
Hamard PJ, Santiago GE, Liu F, Karl DL, Martinez C, Man N, Mookhtiar AK, Duffort S, Greenblatt S, Verdun RE and Nimer SD: PRMT5 regulates DNA repair by controlling the alternative splicing of histone-modifying enzymes. Cell Rep. 24:2643–2657. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Nahon JE, Groeneveldt C, Geerling JJ, van Eck M and Hoekstra M: Inhibition of protein arginine methyltransferase 3 activity selectively impairs liver X receptor-driven transcription of hepatic lipogenic genes in vivo. Br J Pharmaco. 175:3175–3183. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Geng P, Zhang Y, Liu X, Zhang N, Liu Y, Liu X, Lin C, Yan X, Li Z, Wang G, et al: Automethylation of protein arginine methyltransferase 7 and its impact on breast cancer progression. FASEB J. 31:2287–2300. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Vhuiyan MI, Pak ML, Park MA, Thomas D, Lakowski TM, Chalfant CE and Frankel A: PRMT2 interacts with splicing factors and regulates the alternative splicing of BCL-X. J Biochem. 162:17–25. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Hou W, Nemitz S, Schopper S, Nielsen ML, Kessels MM and Qualmann B: Arginine methylation by PRMT2 controls the functions of the actin nucleator cobl. Dev Cell. 45:262–275.e8. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Zhang S, Li L, Wang J, Zhang T, Ye T, Wang S, Xing D and Chen W: Recent advances in the regulation of ABCA1 and ABCG1 by lncRNAs. Clin Chim Acta. 516:100–110. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Li YY, Zhou SH, Chen SS, Zhong J and Wen GB: PRMT2 inhibits the formation of foam cell induced by ox-LDL in RAW 264.7 macrophage involving ABCA1 mediated cholesterol efflux. Biochem Biophys Res Commun. 524:77–82. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Rohatgi A: Reverse cholesterol transport and atherosclerosis. Arterioscler Thromb Vasc Biol. 39:2–4. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Zaiou M and Bakillah A: Epigenetic regulation of ATP-binding cassette protein A1 (ABCA1) gene expression: A new Era to alleviate atherosclerotic cardiovascular disease. Diseases. 6(34)2018.PubMed/NCBI View Article : Google Scholar | |
|
Wang T, Zhao Y, You Z, Li X, Xiong M, Li H and Yan N: Endoplasmic reticulum stress affects cholesterol homeostasis by inhibiting LXR α expression in hepatocytes and macrophages. Nutrients. 12(3088)2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhang M, Zhao GJ, Yin K, Xia XD, Gong D, Zhao ZW, Chen LY, Zheng XL, Tang XE and Tang CK: Apolipoprotein A-1 binding protein inhibits inflammatory signaling pathways by binding to apolipoprotein A-1 in THP-1 macrophages. Circ J. 82:1396–1404. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Hussein MA, Shrestha E, Ouimet M, Barrett TJ, Leone S, Moore KJ, Hérault Y, Fisher EA and Garabedian MJ: LXR-mediated ABCA1 expression and function are modulated by high glucose and PRMT2. PLoS One. 10(e0135218)2015.PubMed/NCBI View Article : Google Scholar | |
|
Ramón-Vázquez A, de la Rosa JV, Tabraue C, Lopez F, Díaz-Chico BN, Bosca L, Tontonoz P, Alemany S and Castrillo A: Common and differential transcriptional actions of nuclear receptors liver X receptors α and β in macrophages. Mol Cell Biol. 39:e00376–18. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Hoekstra M, Nahon JE, de Jong LM, Kröner MJ, de Leeuw LR and Van Eck M: Inhibition of PRMT3 activity reduces hepatic steatosis without altering atherosclerosis susceptibility in ApoE knockout mice. Biochim Biophys Acta Mol Basis Dis. 1865:1402–1409. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Kim DI, Park MJ, Lim SK, Park JI, Yoon KC, Han HJ, Gustafsson JA, Lim JH and Park SH: PRMT3 regulates hepatic lipogenesis through direct interaction with LXRα. Diabetes. 64:60–71. 2015.PubMed/NCBI View Article : Google Scholar | |
|
He PP, Jiang T, OuYang XP, Liang YQ, Zou PQ, Wang Y, Shen QQ, Liao L and Zheng XL: Lipoprotein lipase: Biosynthesis, regulatory factors, and its role in atherosclerosis and other diseases. Clin Chim Acta. 480:126–137. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Wu YT, Li JB, Lin HQ, Zhang GX, Hong CM, Li M, Guo ZJ and Yang YB: Inhibition of miR-200b-3p alleviates lipid accumulation and promotes cholesterol efflux by targeting ABCA1 in macrophage-derived foam cells. Exp Ther Med. 22(831)2021.PubMed/NCBI View Article : Google Scholar | |
|
Vinet M, Suresh S, Maire V, Monchecourt C, Némati F, Lesage L, Pierre F, Ye M, Lescure A, Brisson A, et al: Protein arginine methyltransferase 5: A novel therapeutic target for triple-negative breast cancers. Cancer Med. 8:2414–2428. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Webb LM, Sengupta S, Edell C, Piedra-Quintero ZL, Amici SA, Miranda JN, Bevins M, Kennemer A, Laliotis G, Tsichlis PN and Guerau-de-Arellano M: Protein arginine methyltransferase 5 promotes cholesterol biosynthesis-mediated Th17 responses and autoimmunity. J Clin Invest. 130:1683–1698. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Shimano H and Sato R: SREBP-regulated lipid metabolism: Convergent physiology-divergent pathophysiology. Nat Rev Endocrinol. 13:710–730. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Yang HX, Zhang M, Long SY, Tuo QH, Tian Y, Chen JX, Zhang CP and Liao DF: Cholesterol in LDL receptor recycling and degradation. Clin Chim Acta. 500:81–86. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kober DL, Xu S, Li S, Bajaj B, Liang G, Rosenbaum DM and Radhakrishnan A: Identification of a degradation signal at the carboxy terminus of SREBP2: A new role for this domain in cholesterol homeostasis. Proc Natl Acad Sci USA. 117:28080–28091. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Liu L, Zhao X, Zhao L, Li J, Yang H, Zhu Z, Liu J and Huang G: Arginine methylation of SREBP1a via PRMT5 promotes de novo lipogenesis and tumor growth. Cancer Res. 76:1260–1272. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Yuan HF, Zhao M, Zhao LN, Yun HL, Yang G, Geng Y, Wang YF, Zheng W, Yuan Y, Song TQ, et al: PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours. Acta Pharmacol Sin. 43:2373–2385. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Yoshimoto T, Boehm M, Olive M, Crook MF, San H, Langenickel T and Nabel EG: The arginine methyltransferase PRMT2 binds RB and regulates E2F function. Exp Cell Res. 312:2040–2053. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Chen X, Niroomand F, Liu Z, Zankl A, Katus HA, Jahn L and Tiefenbacher CP: Expression of nitric oxide related enzymes in coronary heart disease. Basic Res Cardiol. 101:346–353. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Doğan I, Eser B, Özkurt S, Yayar O, Özgür B, Kayadibi H, Doğan T, Muşmul A and Soydan M: Serum ADMA, endothelial dysfunction, and atherosclerosis in hypervolemic hemodialysis patients. Turk J Med Sci. 48:1041–1047. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Alpoim PN, Sousa LP, Mota AP, Rios DR and Dusse LM: Asymmetric dimethylarginine (ADMA) in cardiovascular and renal disease. Clin Chim Acta. 440:36–39. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Shafi T, Hostetter TH, Meyer TW, Hwang S, Hai X, Melamed ML, Banerjee T, Coresh J and Powe NR: Serum asymmetric and symmetric dimethylarginine and morbidity and mortality in hemodialysis patients. Am J Kidney Dis. 70:48–58. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Dogan I, Dogan T, Yetim M, Kayadibi H, Yilmaz MB, Eser B, Kalcik M and Karavelioglu Y: Relation of serum ADMA, apelin-13 and LOX-1 levels with inflammatory and echocardiographic parameters in hemodialysis patients. Ther Apher Dial. 22:109–117. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Ito A, Hong C, Oka K, Salazar JV, Diehl C, Witztum JL, Diaz M, Castrillo A, Bensinger SJ, Chan L and Tontonoz P: Cholesterol accumulation in CD11c+ immune cells is a causal and targetable factor in autoimmune disease. Immunity. 45:1311–1326. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Butrous H and Hummel SL: Heart failure in older adults. Can J Cardiol. 32:1140–1147. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Pyun JH, Kim HJ, Jeong MH, Ahn BY, Vuong TA, Lee DI, Choi S, Koo SH, Cho H and Kang JS: Cardiac specific PRMT1 ablation causes heart failure through CaMKII dysregulation. Nat Commun. 9(5107)2018.PubMed/NCBI View Article : Google Scholar | |
|
An X, Lee J, Kim GH, Kim HJ, Pyo HJ, Kwon I and Cho H: Modulation of IKs channel-PIP2 interaction by PRMT1 plays a critical role in the control of cardiac repolarization. J Cell Physiol. 237:3069–3079. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Wang Y, Ju C, Hu J, Huang K and Yang L: PRMT4 overexpression aggravates cardiac remodeling following myocardial infarction by promoting cardiomyocyte apoptosis. Biochem Biophys Res Commun. 520:645–650. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Li Z, Xu J, Song Y, Xin C, Liu L, Hou N, Teng Y, Cheng X, Wang T, Yu Z, et al: PRMT5 prevents dilated cardiomyopathy via suppression of protein O-GlcNAcylation. Circ Res. 129:857–871. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Kim D, Lim S, Park M, Choi J, Kim J, Han H, Yoon K, Kim K, Lim J and Park S: Ubiquitination-dependent CARM1 degradation facilitates notch1-mediated podocyte apoptosis in diabetic nephropathy. Cell Signal. 26:1774–1782. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Roundtree IA, Evans ME, Pan T and He C: Dynamic RNA modifications in gene expression regulation. Cell. 169:1187–1200. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Gao S, Sun H, Chen K, Gu X, Chen H, Jiang L, Chen L, Zhang S, Liu Y, Shi D, et al: Depletion of m6A reader protein YTHDC1 induces dilated cardiomyopathy by abnormal splicing of Titin. J Cell Mol Med. 25:10879–10891. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Roberts AM, Ware JS, Herman DS, Schafer S, Baksi J, Bick AG, Buchan RJ, Walsh R, John S, Wilkinson S, et al: Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med. 7(270ra6)2015.PubMed/NCBI View Article : Google Scholar | |
|
Gong Y, Zhang L, Zhang A, Chen X, Gao P and Zeng Q: GATA4 inhibits cell differentiation and proliferation in pancreatic cancer. PLoS One. 13(e0202449)2018.PubMed/NCBI View Article : Google Scholar | |
|
Chang YM, Chang HH, Lin HJ, Tsai CC, Tsai CT, Chang HN, Lin SL, PadmaViswanadha V, Chen RJ and Huang CY: Inhibition of cardiac hypertrophy effects in d-galactose-induced senescent hearts by alpinate oxyphyllae fructus treatment. Evid Based Complement Alternat Med. 2017(2624384)2017.PubMed/NCBI View Article : Google Scholar | |
|
Glenn DJ, Rahmutula D, Nishimoto M, Liang F and Gardner DG: Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism. Cardiovasc Res. 84:209–217. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Zhang G, Wang X, Bi X, Li C, Deng Y, Al-Hashimi AA, Luo X, Gillette TG, Austin RC, Wang Y and Wang ZV: GRP78 (glucose-regulated protein of 78 kDa) promotes cardiomyocyte growth through activation of GATA4 (GATA-binding protein 4). Hypertension. 73:390–398. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Chen M, Yi B and Sun J: Inhibition of cardiomyocyte hypertrophy by protein arginine methyltransferase 5. J Biol Chem. 289:24325–24335. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Cai S, Liu R, Wang P, Li J, Xie T, Wang M, Cao Y, Li Z and Liu P: PRMT5 prevents cardiomyocyte hypertrophy via symmetric demethylating HoxA9 and repressing HoxA9 expression. Front Pharmacol. 11(600627)2020.PubMed/NCBI View Article : Google Scholar | |
|
Bouchard C, Sahu P, Meixner M, Nötzold RR, Rust MB, Kremmer E, Feederle R, Hart-Smith G, Finkernagel F, Bartkuhn M, et al: Genomic location of PRMT6-dependent H3R2 methylation is linked to the transcriptional outcome of associated genes. Cell Rep. 24:3339–3352. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Raveendran VV, Al-Haffar K, Kunhi M, Belhaj K, Al-Habeeb W, Al-Buraiki J, Eyjolsson A and Poizat C: Protein arginine methyltransferase 6 mediates cardiac hypertrophy by differential regulation of histone H3 arginine methylation. Heliyon. 6(e03864)2020.PubMed/NCBI View Article : Google Scholar | |
|
Cheng D, Gao G, Di Lorenzo A, Jayne S, Hottiger MO, Richard S and Bedford MT: Genetic evidence for partial redundancy between the arginine methyltransferases CARM1 and PRMT6. J Biol Chem. 295:17060–17070. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Liu F, Wan L, Zou H, Pan Z, Zhou W and Lu X: PRMT7 promotes the growth of renal cell carcinoma through modulating the β-catenin/C-MYC axis. Int J Biochem Cell Biol. 120(105686)2020.PubMed/NCBI View Article : Google Scholar | |
|
Ahn BY, Jeong MH, Pyun JH, Jeong HJ, Vuong TA, Bae JH, An S, Kim SK, Kim YK, Ryu D, et al: PRMT7 ablation in cardiomyocytes causes cardiac hypertrophy and fibrosis through β-catenin dysregulation. Cell Mol Life Sci. 79(99)2022.PubMed/NCBI View Article : Google Scholar | |
|
Bergmann ME: WNT signaling in adult cardiac hypertrophy and remodeling: Lessons learned from cardiac development. Circ Res. 107:1198–1208. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Angers S and Moon RT: Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol. 10:468–477. 2009.PubMed/NCBI View Article : Google Scholar | |
|
MacDonald BT, Tamai K and He X: Wnt/beta-catenin signaling: Components, mechanisms, and diseases. Dev Cell. 17:9–26. 2009.PubMed/NCBI View Article : Google Scholar |
